Skip to content
10-K

Annual Report

GRI Bio, Inc. GRI

0001824293-26-000033

← back to feed
Filed
Jan 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 29, 2026 1.45M sh
Shares Diluted FY 2025 · Dec 31, 2025 98.16K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 6.55K sh
Capex FY 2025 · Dec 31, 2025 $3K
Capex FY 2025 · Dec 31, 2024 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 −$10.19M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$8.61M
Cash And Equivalents FY 2025 · Dec 31, 2025 $8.23M
Cash And Equivalents FY 2025 · Dec 31, 2024 $5.03M
Stockholders Equity FY 2025 · Dec 31, 2025 $6.01M
Stockholders Equity FY 2025 · Dec 31, 2024 $4.03M
Stockholders Equity FY 2025 · Dec 31, 2023 $259K
Current Liabilities FY 2025 · Dec 31, 2025 $2.64M
Current Liabilities FY 2025 · Dec 31, 2024 $1.64M
Total Liabilities FY 2025 · Dec 31, 2025 $2.66M
Total Liabilities FY 2025 · Dec 31, 2024 $1.71M
Current Assets FY 2025 · Dec 31, 2025 $8.59M
Current Assets FY 2025 · Dec 31, 2024 $5.62M
Total Assets FY 2025 · Dec 31, 2025 $8.67M
Total Assets FY 2025 · Dec 31, 2024 $5.74M
Eps Diluted FY 2025 · Dec 31, 2025 −$121.80
Eps Diluted restated FY 2025 · Dec 31, 2024 −$1,545.55
Eps Basic FY 2025 · Dec 31, 2025 −$121.80
Eps Basic restated FY 2025 · Dec 31, 2024 −$1,545.55
Rd Expense FY 2025 · Dec 31, 2025 $6.82M
Rd Expense FY 2025 · Dec 31, 2024 $3.77M
Net Income FY 2025 · Dec 31, 2025 −$11.96M
Net Income FY 2025 · Dec 31, 2024 −$8.21M
Operating Income FY 2025 · Dec 31, 2025 −$11.98M
Operating Income FY 2025 · Dec 31, 2024 −$8.24M